Biosense Webster, a Johnson & Johnson-owned company focused on cardiac arrhythmia treatment, announced that several of its catheter products have received FDA approval for a zero fluoroscopy workflow, according to an Aug. 4 news release.
Read the full post on Becker's Hospital Review - Healthcare News
